Inventor · disambiguated record
Kelly Carles-Kinch
Also filed as: CARLES-KINCH KELLY
3 granted patents·15 pending applications·57 citations·filing 2001–2011
74Inventor score
Files withMEDIMMUNE INC5MEDIMMUNE LLC4KINCH MICHAEL S2PURDUE RESEARCH FOUNDATION2PURDUE RES FOUNDATION AND MEDI1
Top patents by PatentIndex Score
18 records- 0190US7101976B1EphA2 monoclonal antibodies and methods of making and using sameSMITHKLINE BEECHAM CORP·Filed 2001·Granted Sep 5, 2006·34 cites·21 claims
- 0283US7402298B1EphA2 monoclonal antibodies and methods of making and using samePURDUE RESEARCH FOUNDATION·Filed 2004·Granted Jul 22, 2008·11 cites·9 claims
- 0381US7604799B2EphA4 AntibodiesMEDIMMUNE LLC·Filed 2004·Granted Oct 20, 2009·12 cites·9 claims
- 0463US2010143345A1Epha2 agonistic monoclonal antibodies and methods of use thereofMEDIMMUNE LLC·Filed 2009·Application pending·0 cites
- 0562US2005152899A1EphA2 agonistic monoclonal antibodies and methods of use thereofFiled 2004·Application pending·0 cites
- 0659US2010298545A1EphA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOFKINCH MICHAEL S·Filed 2009·Application pending·0 cites
- 0759US2010166657A1USE OF EphA4 AND MODULATOR OF EphA4 FOR DIAGNOSIS, TREATMENT AND PREVENTION OF CANCERMEDIMMUNE LLC·Filed 2009·Application pending·0 cites
- 0859US2010260749A1Modulators of EphA2 and Ephrin-A1 for the treatment of fibrosis-related diseaseMEDIMMUNE INC·Filed 2008·Application pending·0 cites
- 0958US2004091486A1EphA2 agonistic monoclonal antibodies and methods of use thereofFiled 2003·Application pending·0 cites
- 1057US2007134254A1EphA2 agonistic monoclonal antibodies and methods of use thereofPURDUE RESEARCH FOUNDATION·Filed 2007·Application pending·0 cites
- 1157US2007166314A1EpA2 monoclonal antibodies and methods of use thereofMEDIMMUNE INC·Filed 2007·Application pending·0 cites
- 1254US2007086943A1EphA2 agonistic monoclonal antibodies and methods of use thereofPURDUE RES FOUNDATION AND MEDI·Filed 2006·Application pending·0 cites
- 1352US2006122138A1Modulators of EphA2 and EphrinA1 for the treatment of fibrosis-related diseaseMEDIMMUNE INC·Filed 2005·Application pending·0 cites
- 1451US2004028685A1EphA2 monoclonal antibodies and methods of use thereofFiled 2003·Application pending·0 cites
- 1547US2010278838A1Epha2 monoclonal antibodies and methods of use thereofMEDIMMUNE LLC·Filed 2010·Application pending·0 cites
- 1644US2012121582A1Modulators Of EphA2 And Ephrina1 For The Treatment Of Fibrosis-Related DiseaseKINCH MICHAEL S·Filed 2011·Application pending·0 cites
- 1743US2006121042A1Modulation of antibody specificity by tailoring the affinity to cognate antigensMEDIMMUNE INC·Filed 2005·Application pending·0 cites
- 1840US2006121043A1Use of modulators of EphA2 and EphrinA1 for the treatment and prevention of infectionsMEDIMMUNE INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kelly Carles-Kinch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →